Delayed 5-day change 1st Jan Change
- USD -.--% Intraday chart for ReGen Biologics Inc. -.--% -

Valuation: ReGen Biologics Inc.

Market Cap 1.17M 1.04M 967K 880K 1.66M 111M 1.69M 11.62M 4.56M 58.12M 4.4M 4.31M 185M P/E 2007
-0.9x
P/E 2008 -1.66x
Enterprise Value 11.46M 10.19M 9.44M 8.59M 16.21M 1.09B 16.47M 113M 44.49M 567M 43M 42.09M 1.81B EV / Sales 2007
14x
EV / Sales 2008 22.7x
Free-Float
100%
Yield 2007 *
-
Yield 2008 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 25
+0.20%+5.31%-18.40%+13.84% 181B
-0.73%+7.09%-1.08%+30.13% 116B
+0.49%+6.25%-21.30%+9.62% 113B
+3.83%+5.50%-50.59%-6.11% 79.83B
-0.14%+5.27%+5.00%+81.87% 65.06B
+2.79%+2.37%+15.85%+65.97% 54.35B
-1.04%+4.35%+1.40%-26.05% 52.23B
+2.41%+8.18%-11.81%+28.50% 44.15B
-1.90%+2.29%+29.19%+6.90% 32.47B
Average +0.59%+4.76%-5.75%+22.74% 73.86B
Weighted average by Cap. +0.60%+5.59%-11.14%+21.17%

Financials

2007 2008
Net sales 986K 876K 812K 739K 1.39M 93.58M 1.42M 9.76M 3.83M 48.83M 3.7M 3.62M 156M 1.37M 1.22M 1.13M 1.03M 1.94M 130M 1.97M 13.61M 5.34M 68.05M 5.16M 5.05M 217M
Net income -10.38M -9.22M -8.55M -7.78M -14.68M -985M -14.91M -103M -40.29M -514M -38.94M -38.12M -1.64B -9.95M -8.85M -8.2M -7.46M -14.08M -944M -14.3M -98.55M -38.64M -493M -37.35M -36.55M -1.57B
Net Debt 4.09M 3.64M 3.37M 3.07M 5.79M 388M 5.88M 40.53M 15.89M 203M 15.36M 15.03M 646M 10.28M 9.14M 8.47M 7.71M 14.55M 976M 14.78M 102M 39.94M 509M 38.6M 37.78M 1.62B
Logo ReGen Biologics Inc.
Regen Biologics Inc (ReGen) is a United States-based development stage orthopedic products company. The Company develops, manufactures and markets tissue growth and repair products for United States and global markets. The Company's collagen matrix technology includes applications in orthopedics, general surgery, spine, cardiovascular and drug delivery. Some of these applications are marketable while others are in various stages of development. Its approved product using its collagen matrix technology is the Menaflex collagen meniscus implant device (also known as the CMI), which is marketed for sale in the European Union (EU), Switzerland, Turkey, and the Republic of South Africa, through the Company’s subsidiary, ReGen Biologics AG.
Employees
-
  1. Stock Market
  2. Stocks
  3. RGBOQ Stock